Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2017 Apr 1;56(4):556-560.
doi: 10.1093/rheumatology/kew371.

Na+ deposition in the fibrotic skin of systemic sclerosis patients detected by 23Na-magnetic resonance imaging

Affiliations
Observational Study

Na+ deposition in the fibrotic skin of systemic sclerosis patients detected by 23Na-magnetic resonance imaging

Christoph Kopp et al. Rheumatology (Oxford). .

Erratum in

Abstract

Objective: Skin fibrosis is the predominant feature of SSc and arises from excessive extracellular matrix deposition. Glycosaminoglycans are macromolecules of the extracellular matrix, which facilitate Na + accumulation in the skin. We used 23 Na-MRI to quantify Na + in skin. We hypothesized that skin Na + might accumulate in SSc and might be a biomarker for skin fibrosis.

Methods: In this observational case-control study, skin Na + was determined by 23 Na-MRI using a Na + volume coil in 12 patients with diffuse cutaneous SSc and in 21 control subjects. We assessed skin fibrosis by the modified Rodnan skin score prior to 23 Na-MRI and on follow-up 12 months later.

Results: 23 Na-MRI demonstrated increased Na + in the fibrotic skin of SSc patients compared with skin from controls [mean ( s . d .): 27.2 (5.6) vs 21.4 (5.3) mmol/l, P < 0.01]. Na + content was higher in fibrotic than in non-fibrotic SSc skin [26.2 (4.8) vs 19.2 (3.4) mmol/l, P < 0.01]. Furthermore, skin Na + amount was correlated with changes in follow-up modified Rodnan skin score (R 2 = 0.68).

Conclusions: 23 Na-MRI detected increased Na + in the fibrotic SSc skin; high Na + content was associated with progressive skin disease. Our findings provide the first evidence that 23 Na-MRI might be a promising tool to assess skin Na + and thereby predict progression of skin fibrosis in SSc.

Keywords: 23Na-MRI; extracellular matrix; fibrosis; skin Na+; systemic sclerosis.

PubMed Disclaimer

Figures

F<sc>ig</sc>. 1
Fig. 1
23Na-MRI detects increased Na+ in fibrotic SSc skin and discriminates between affected and non-affected skin (AC) Skin Na+ (A) and water content (B) of SSc patients (n = 12) and age-matched controls (n = 21) quantified by 23Na-MRI and 1H-MRI. (C) Representative23Na-MRI detects increased Na+ in fibrotic SSc skin and discriminates between affected and non-affected skin. 23Na- and 1H-magnetic resonance images of healthy (left) and fibrotic skin (right). Calibration tubes are placed below the forearm. Arrows indicate the site of measurement. (D) Skin Na+ content in fibrotic forearm vs non-involved lower leg in the same patients (n = 11). (E) Skin Na+ content of non-affected SSc skin vs healthy control patients (both lower leg). (F) Representative 23Na-magnetic resonance images of the forearm vs lower leg of an SSc patient.
F<sc>ig</sc>.
2
Fig. 2
Skin Na+ correlates with change of the modified Rodnan skin score and EULAR Scleroderma Trials and Research Disease Activity Score (A) The mRSS was assessed at the time of 23Na-MRI and 12 months later at a follow-up visit in 11 out of 12 patients. The initial mRSS was substracted from the follow-up mRSS (ΔmRSS) to describe the course of the fibrotic skin disease. (B) The EUSTAR DAS was determined at the first visit together with 23Na-MRI in all SSc patients. The amount of Na+ in the forearm skin assessed by 23Na-MRI was positively correlated with the EUSTAR DAS. EUSTAR: EULAR Scleroderma Trials and Research; mRSS: modified Rodnan skin score.

Similar articles

Cited by

References

    1. Tyndall AJ, Bannert B, Vonk M. et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010;69:1809–15. - PubMed
    1. Varga J, Abraham D.. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007;117:557–67. - PMC - PubMed
    1. Wight TN, Potter-Perigo S.. The extracellular matrix: an active or passive player in fibrosis? Am J Physiol Gastrointest Liver Physiol 2011;301:G950–5. - PMC - PubMed
    1. Søndergaard K, Heickendorff L, Risteli L. et al. Increased levels of type I and III collagen and hyaluronan in scleroderma skin. Br J Dermatol 1997;136:47–53. - PubMed
    1. Bashey RI, Millan A, Jimenez SA.. Increased biosynthesis of glycosaminoglycans by scleroderma fibroblasts in culture. Arthritis Rheum 1984;27:1040–5. - PubMed

Publication types